elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q27310843-21FE144A-CAD6-4E30-8347-36250291B732
Q27310843-21FE144A-CAD6-4E30-8347-36250291B732
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27310843-21FE144A-CAD6-4E30-8347-36250291B732
Phase 1/2 trials of Temozolomide, Motexafin Gadolinium, and 60-Gy fractionated radiation for newly diagnosed supratentorial glioblastoma multiforme: final results of RTOG 0513.
P2860
Q27310843-21FE144A-CAD6-4E30-8347-36250291B732
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27310843-21FE144A-CAD6-4E30-8347-36250291B732
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
be3272822b0bd39c30fc2034869ef0480287d024
P2860
Response criteria for phase II studies of supratentorial malignant glioma.